Identity
Bristol-Myers Squibb, S.A.U.
| Year | Amount | Distribution |
|---|---|---|
| 2026* | €152.1M | |
| 2025 | €79.8M | |
| 2024 | €61.7M | |
| + regional platforms | ||
| 2023 | €11.2M | |
| 2022 | €23.6M | |
| 2021 | €30.8M | |
| 2020 | €4.4M | |
| 2019 | €14.4M | |
| 2018 | — | |
| 2017 | €2.9M | |
| 2016 | €0.7M | |
In figures
Volume
Between 2016 and 2026 it won 445 contracts worth €382M on its own, with 38 buyers. Its 2 joint-venture (UTE) contracts are shown separately.
Price
It has fewer than 3 comparable awards, too few to compute its median discount.
Competition
Since 2024, 0% of its comparable value was won with a discount and against other bidders. It was the only bidder in 95% of its contracts (2016–2026).
Renewals
64 contracts (€29.1M) come up for tender again in the next 24 months.
A UTE is a temporary joint venture: the contract is awarded to the UTE and each partner's share is not published. That is why these contracts are not added to Bristol-Myers Squibb, S.A.U.'s total, and under «Show UTEs» the amounts are the full value of each contract (100%), not Bristol-Myers Squibb, S.A.U.'s share.
Data up to 31 October 2026 · updated on 12 November 2026 · Source: official data, national and regional coverage
| UTE partners | Contracts | Total value (100 %) |
|---|
Its discounts
The discount at which it wins contested contracts, year by year.
There are no contested awards to analyse. Of its 445 contracts, 266 are call-offs under framework agreements and 88 cannot be compared against their budget.
Framework call-offs 266 · Single bidder 5 · Non-competitive procedure 86 · No comparable budget 88 · Contested, comparable 0
Where it wins, and at what discount
In the report · these discounts, one by one
Each dot on the chart is an award. The report lists them all and groups them by buyer and by sector, next to the discounts of other companies with the same buyers.
Full list: date, buyer, amount, budget, discount, bidders and a link to the official publication.
How it wins
Whether it wins with or without competition.
100% of the comparable value since 2024 (€2.59M of €2.59M) was won at the tender price and without other bidders.
Comparable: 5 awards with a published budget and bidder count (€2.59M of €294M awarded since 2024). Percentages of value; the figure next to «bidders» is the number of awards. Source: official data, national and regional coverage.
Between 2016 and 2026, 83.4% of the value was awarded through negotiated without publicity procedure (57.6% of contracts); followed by Other (6.4%) and Based on a framework agreement (6.2%).
Upcoming tenders and main buyers
When its contracts come back and who it sells to.
In the next 24 months 64 of its contracts come up for tender again, worth €29.1M.
| Expected end | Buyer | Value |
|---|---|---|
| 2026 | Hospital Universitario de Fuenlabrada | €262k |
| 2026 | Hospital Universitario Clínico San Carlos | €236k |
| 2026 | Hospital Universitario Clínico San Carlos | €35.0k |
| 2026 | Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad | — |
| 2026 | Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad | — |
and 59 more in the next 24 months · the report includes them all
Expected end year from the published duration (no extensions). The report includes the month and the discount it won each one at.
| Buyer | Contracts | Value, € | Period |
|---|---|---|---|
| OSAKIDETZA - Servicio Vasco de Salud -Director General | 17 | 142 M | 2024–2026 |
| Gerencia de Servicio Sanitarios de Fuerteventura | 195 | 43 M | 2019–2026 |
| Servicio Andaluz de Salud | 48 | 42 M | 2024–2026 |
| Servicio Murciano de Salud - Junta de Compras | 32 | 36 M | 2021–2025 |
| Subsecretaría de la Consellería de Sanidad y Salud Pública | 9 | 22 M | 2022–2025 |
and 33 more buyers
Between 2016 and 2026, 99.2% of the value it won on its own is in Medical & pharmaceuticals (CPV 33, 433 contracts); followed by Repair & maintenance (CPV 50), with 0.8%.
Recent awards
The evidence behind every insight in the report.
| Date | Contract | Buyer | Bidders | Value |
|---|---|---|---|---|
| 06/07/2026 | Suministro de Lisocabtagen Maraleucel "Emergencia". | Servicio Cántabro de Salud | 1 | — |
| 06/07/2026 | Suministro de Lisocabtagen Maraleucel "Emergencia". | Servicio Cántabro de Salud | 1 | — |
| 03/07/2026 | Suministro De Medicamentos De Uso Humano Tipo Ii (Exclusivos), Con Destino Al Servicio De Farmacia … | Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria | 1 | €20.5k |
| 02/07/2026 | Suministro de Lisocabtagen Maraleucel "Emergencia". | Servicio Cántabro de Salud | 1 | — |
| 18/06/2026 | Suministro de medicamentos de uso humano tipo II(exclusivos), lote 63, con destino al servicio de f… | Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria | 1 | €6.58k |